BeneChill Garners New Venture Capital Equity
Friday, February 22, 2013 5:56:00 AM PDT | VentureDeal
   San Diego, California  --  Medical technology firm BeneChill has secured nearly $6.6 million in new venture capital equity investment, according to an SEC regulatory filing.

BeneChill is developing technology that reduces tissue damage in patients with cerebral ischemia.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

BeneChill is still seeking $2.9 million in additional financing, according to the filing.